Newsroom
Welcome to the GoodCell Newsroom for the latest industry news and analysis, expert insights into the field of cellular therapies and personal biobanking from our founders and scientific advisory board, updates about our offerings, plus a little bit about working at GoodCell.
Unlocking the Secrets of
COVID-19 In Our Cells
Emerging research suggests that certain biomarkers could be early indicators of a potential excessive inflammatory response and that this information, paired with genetic analysis, including both inherited genetic predispositions and genetic damage accumulated as we age, could provide researchers and doctors with a better means for stratifying those at the greatest risk for the most adverse outcomes.
Read More
Vox Looks at What’s Next for DTC Genetic Testing
Amidst news of 23andMe and Ancestry layoffs, Vox spoke with GoodCell CEO and co-founder Trevor Perry on market saturation and limited utility of existing DNA kits.
Read More
Previous
Next

Recent Posts

Media & Press

Amidst news of 23andMe and Ancestry layoffs, Vox spoke with GoodCell CEO and co-founder Trevor Perry on market saturation and limited utility of existing DNA kits. As consumers look for a more holistic approach to health, GoodCell is among the companies leading the charge by providing health-conscious customers with a long-term testing and cell storage solution. This approach is enabling consumers to reap benefits beyond a one-and-done test and preparing them to take advantage of the latest medical breakthrough.
Startup LifeVault Bio, which offers personal biobanking, small-panel genetic testing, and analysis under the GoodCell name, is trying to break new ground by creating metrics for measuring cell quality.